2-piperidone has been researched along with Coronary Restenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bratasz, A; Hideg, K; Kálai, T; Kuppusamy, ML; Kuppusamy, P; Rink, C; Rivera, BK; Selvendiran, K; Sen, CK; Tong, L | 1 |
1 other study(ies) available for 2-piperidone and Coronary Restenosis
| Article | Year |
|---|---|
Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression.
Topics: Activating Transcription Factor 2; Animals; Apoptosis; Benzylidene Compounds; Carotid Arteries; Caspase 3; Cell Cycle; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Curcumin; G1 Phase; Gene Expression; Growth Inhibitors; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Piperidones; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; RNA, Small Interfering | 2009 |